- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Breast imaging technique zeros in on subcentimeter lesions
A new gamma camera developed by researchers at the Mayo Clinic in Rochester, MN, is being used in what’s touted as a molecular breast imaging technique.
A new gamma camera developed by researchers at the Mayo Clinic in Rochester, MN, is being used in what's touted as a molecular breast imaging technique.
Unlike conventional scintimammography, which uses sodium iodide crystals, the Mayo camera uses a cadmium-zinc-telluride semiconductor detector. The detector can be placed very close to the breast, eliminating the dead space associated with conventional scintimammography.
This close positioning provides much better resolution, improving the ability to detect small lesions, said Dr. Deborah J. Rhodes, director of the women's executive health program at Mayo.
Rhodes and colleagues mounted the gamma camera, with a field-of-view of 20 x 20 cm and detector elements of 2.5 x 2.5 mm, onto a modified mammographic gantry. Between November 2001 and March 2004, they imaged 40 women who were scheduled to undergo biopsy. The study was published in the January issue of the Mayo Clinic Proceedings.
Using 20 mCi of technetium-99m sestamibi, they obtained craniocaudal and mediolateral oblique views of both breasts.
The imaging technique detected 33 of 36 lesions confirmed to be malignant by surgery, for an overall sensitivity of 92%. It detected 19 of 22 surgery-confirmed lesions smaller than 1 cm, for a sensitivity of 86%.
Because molecular breast imaging is not influenced by breast density and is much less costly than MRI, the technique may be more appropriate than MRI as a screening tool in high-risk women, Rhodes said.
"We feel this type of imaging fills a critical gap in breast imaging options. It will not replace mammograms, ultrasound, or MRI but will offer an important additional option to subgroups of women not served well by traditional imaging techniques, such as women with dense breast tissue, women with prior surgery or radiation of the breast, and many other potential groups," she said.
For more information from the Diagnostic Imaging archives:
Technique adds dimension to nuclear mammography
Breast MR builds its role among high-risk patients
Radiology's role grows in biopsy decisions, procedures
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
